Fapon Showcases Innovative IVD Solutions at ADLM 2025 in Chicago

Fapon at ADLM 2025: A New Era for IVD Solutions

Fapon, a renowned leader in the life sciences sector, is set to unveil its state-of-the-art one-stop in-vitro diagnostic (IVD) solutions at the upcoming ADLM 2025 conference, scheduled from July 29 to July 31 in Chicago, Illinois. This event marks a pivotal moment for Fapon as it strengthens its presence in the North American market, particularly aiming to become the preferred partner for laboratories and IVD manufacturers.

Comprehensive and Tailored IVD Innovations

At ADLM 2025, Fapon will present a diverse array of high-performance raw materials and customized reagent services, alongside open-system instruments designed specifically for North American laboratories. Noteworthy products include a novel mouse-free IgG blocker and advanced antibodies for cardiac marker assays, specifically Fapon's fourth-generation NT-proBNP and ultra-sensitive hs-cTnI. The company also offers a comprehensive range of diagnostic products tailored for the U.S. market, covering various assays for conditions such as influenza A/B, HIV, HCV, and vitamin D, among others. In the realm of molecular diagnostics, Fapon is set to showcase solutions for quantitative PCR (qPCR), isothermal amplification, and Next-Generation Sequencing (NGS), featuring groundbreaking products like the ProPrime Taq DNA polymerase and the NextGen universal FS DNA library preparation kit. Notably, Fapon's enzyme innovations are driven by artificial intelligence, showcasing the company's commitment to integrating cutting-edge technology.

Introducing the Shine mT8000

Fapon is excited to expand its open-system instruments portfolio with the introduction of the Shine mT8000, which seamlessly integrates biochemistry and immunoassay functionalities to bolster laboratory efficiency. Additionally, the Shine i-series CLIA analyzers cater to various testing throughputs, while compact immunofluorescence and PCR instruments are available for a wide array of testing scenarios. This expansion reflects Fapon's commitment to providing laboratories with flexible, efficient, and comprehensive diagnostic tools.

Pioneering R&D Capabilities

With over two decades of experience, Fapon has established itself as a leader in innovation within the diagnostics field. The company boasts advanced technology platforms encompassing antibody discovery, protein expression, cell fermentation, and protein purification. To further enhance its R&D capabilities, Fapon has set up centers in Boston, focusing on developing molecular diagnostic enzymes and circRNA technologies, and another in San Francisco concentrating on NGS and AI-driven life science innovations. This strategic setup enables Fapon to deliver groundbreaking diagnostic solutions that meet the evolving needs of healthcare providers.

A Strong Commitment to the U.S. Market

Fapon’s strategy emphasizes localization, understanding that tailored solutions are vital for success in the U.S. market. The company has established R&D and production facilities based in the United States, allowing it to better address customer needs and maintain high-quality standards. Fapon's commitment to excellence is reflected in its adherence to stringent ISO certifications, including ISO 13485, ISO 9001, ISO 14001, and ISO 45001, ensuring reliable and consistent product delivery.

Visit Fapon at ADLM 2025

Attendees of ADLM 2025 are encouraged to visit booth No. 3816 to explore Fapon's innovative one-stop IVD solutions. The event provides an excellent opportunity to engage with Fapon's team and discover more about their cutting-edge products and services that are poised to revolutionize diagnostic technology in North America.

About Fapon

Fapon is a global leader in the life sciences sector, focusing on integrated solutions and services encompassing diagnostics, biopharma, and biotherapy. By offering a one-stop solution that combines raw materials, reagents, and innovative open instrument platforms, Fapon has emerged as a significant supplier in the IVD market. With a robust global R&D, manufacturing, sales, and service network, Fapon's products are present in over 70 countries, supporting more than 2,500 business partners worldwide. Stay connected with Fapon on LinkedIn and visit their website for more information.